{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-007954","form_type":"8-K","ticker":"AIM","cik":"0000946644","company_name":"AIM ImmunoTech Inc.","filed_at":"2025-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.909368+00:00","generated_at":"2026-05-23T01:46:01.002092+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"AIM ImmunoTech shareholders approve reverse stock split up to 1-for-100","bullets":["Special meeting held April 30, 2025; proposal passed with 23,041,332 for, 19,942,903 against.","Board may enact reverse split at any ratio up to 1-for-100 at its sole discretion.","Split intended to increase per-share price; no specific ratio or effective date announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-007954","json":"https://secwatch.observer/filing/0001641172-25-007954.json","markdown":"https://secwatch.observer/filing/0001641172-25-007954.md","text":"https://secwatch.observer/filing/0001641172-25-007954.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946644/000164117225007954/0001641172-25-007954-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946644/000164117225007954/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T01:46:01.002092+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}